688526 科前生物
交易中 08-13 09:52:40
资讯
新帖
简况
股市必读：科前生物新发布《武汉科前生物股份有限公司关于拟与华中农大签订合作研发协议暨关联交易的自愿性披露公告》
证券之星 · 08-12 02:36
股市必读：科前生物新发布《武汉科前生物股份有限公司关于拟与华中农大签订合作研发协议暨关联交易的自愿性披露公告》
科前生物(688526.SH)拟与华中农大签订合作研发协议
智通财经 · 08-11 16:00
科前生物(688526.SH)拟与华中农大签订合作研发协议
股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》
证券之星 · 08-03
股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》
每周股票复盘：科前生物（688526）获两项新兽药注册证
证券之星 · 08-02
每周股票复盘：科前生物（688526）获两项新兽药注册证
科前生物（688526）披露获批两项新兽药注册证书，7月30日股价上涨0.48%
证券之星 · 07-30
科前生物（688526）披露获批两项新兽药注册证书，7月30日股价上涨0.48%
科前生物（688526）披露拟签订合作研发协议暨关联交易公告，7月14日股价上涨1.18%
证券之星 · 07-14
科前生物（688526）披露拟签订合作研发协议暨关联交易公告，7月14日股价上涨1.18%
每周股票复盘：科前生物（688526）将举办2025年度业绩说明会
证券之星 · 07-05
每周股票复盘：科前生物（688526）将举办2025年度业绩说明会
科前生物获得发明专利授权：“猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法”
证券之星 · 07-04
科前生物获得发明专利授权：“猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法”
科前生物（688526）披露将参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，7月01日股价上涨5.12%
证券之星 · 07-01
科前生物（688526）披露将参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，7月01日股价上涨5.12%
太平洋：给予科前生物买入评级
证券之星 · 06-15
太平洋：给予科前生物买入评级
科前生物新注册《腺病毒密码子优化软件1.0》等3个项目的软件著作权
证券之星 · 05-26
科前生物新注册《腺病毒密码子优化软件1.0》等3个项目的软件著作权
每周股票复盘：科前生物（688526）每股派现0.64元（含税）
证券之星 · 05-24
每周股票复盘：科前生物（688526）每股派现0.64元（含税）
科前生物（688526）披露2025年年度权益分派实施公告，5月20日股价下跌0.28%
证券之星 · 05-20
科前生物（688526）披露2025年年度权益分派实施公告，5月20日股价下跌0.28%
股市必读：科前生物一季报 - 第一季度单季净利润同比下降26.79%
证券之星 · 05-06
股市必读：科前生物一季报 - 第一季度单季净利润同比下降26.79%
东兴证券：给予科前生物买入评级
证券之星 · 05-05
东兴证券：给予科前生物买入评级
每周股票复盘：科前生物（688526）一季度净利降26.79%
证券之星 · 05-02
每周股票复盘：科前生物（688526）一季度净利降26.79%
科前生物（688526）2026年一季报简析：净利润同比下降26.79%，公司应收账款体量较大
证券之星 · 05-01
科前生物（688526）2026年一季报简析：净利润同比下降26.79%，公司应收账款体量较大
科前生物(688526)3月31日股东户数1.07万户，较上期增加0.05%
证券之星 · 04-30
科前生物(688526)3月31日股东户数1.07万户，较上期增加0.05%
图解科前生物一季报：第一季度单季净利润同比下降26.79%
证券之星 · 04-30
图解科前生物一季报：第一季度单季净利润同比下降26.79%
每周股票复盘：科前生物（688526）2025年净利增9.51%
证券之星 · 04-19
每周股票复盘：科前生物（688526）2025年净利增9.51%
加载更多
公司概况
公司名称：
武汉科前生物股份有限公司
所属行业：
医药制造业
上市日期：
2020-09-22
主营业务：
武汉科前生物股份有限公司的主营业务是专注于兽用生物制品研发、生产、销售及动物防疫技术服务。公司的主要产品是兽用生物制品。公司共获得2项国家科学技术进步奖二等奖、6项湖北省科技进步奖一等奖、1项湖北省科技进步二等奖，5项国家重点新产品证书。
发行价格：
11.69
{"stockData":{"symbol":"688526","market":"SH","secType":"STK","nameCN":"科前生物","latestPrice":13,"timestamp":1786585960000,"preClose":13.16,"halted":0,"volume":306708,"delay":0,"changeRate":-0.0122,"floatShares":466000000,"shares":466000000,"eps":0.8361,"marketStatus":"交易中","change":-0.16,"latestTime":"08-13 09:52:40","open":13.08,"high":13.15,"low":12.96,"amount":3998100,"amplitude":0.0144,"askPrice":13.03,"askSize":10,"bidPrice":13,"bidSize":13,"shortable":0,"etf":0,"ttmEps":0.8361,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786591800000},"marketStatusCode":2,"adr":0,"adjPreClose":13.16,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786584600000,1786591800000],[1786597200000,1786604400000]],"highLimit":14.48,"lowLimit":11.84,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":466128056,"isCdr":false,"pbRate":1.42,"roa":"--","peRate":15.548379,"roe":"1.85%","epsLYR":0.9,"committee":0.269113,"marketValue":6060000000,"turnoverRate":0.0007,"status":1,"floatMarketCap":6060000000},"requestUrl":"/m/hq/s/688526","defaultTab":"news","newsList":[{"id":"2658917011","title":"股市必读：科前生物新发布《武汉科前生物股份有限公司关于拟与华中农大签订合作研发协议暨关联交易的自愿性披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658917011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658917011?lang=zh_cn&edition=full","pubTime":"2026-08-12 02:36","pubTimestamp":1786473374,"startTime":"0","endTime":"0","summary":"武汉科前生物股份有限公司独立董事关于第四届董事会第二十三次会议相关事项的独立意见独立董事认为公司拟与华中农大签订合作研发协议有利于提升公司在生物制品领域的核心竞争力，推动公司发展；该关联交易表决程序合法，交易价格公允，未损害公司及全体股东利益；独立董事一致同意本次关联交易事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200002335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658998187","title":"科前生物(688526.SH)拟与华中农大签订合作研发协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998187","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658998187?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:00","pubTimestamp":1786435219,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科前生物(688526.SH)发布公告，公司经与华中农业大学(下称“华中农大”)竞争性谈判，取得了“猪流行性腹泻病毒乳胶微球检测试纸条”、“猪流行性腹泻亚单位疫苗”两个项目的合作研发，现拟与华中农大签订联合开发协议书，公司就以上两个研发项目一共需向华中农大支付200万元。合作研发项目产生的技术成果及知识产权归公司及华中农大共同所有。通过合作研发，可以增加公司产品储备，提升公司市场竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656343713","title":"股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656343713","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656343713?lang=zh_cn&edition=full","pubTime":"2026-08-03 03:40","pubTimestamp":1785699622,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，科前生物报收于13.03元，上涨2.68%，换手率0.44%，成交量2.07万手，成交额2660.9万元。当日关注点交易信息汇总：7月31日主力资金净流出2.08万元，游资净流出144.63万元，散户净流入146.71万元。公司公告汇总：科前生物获批两项新兽药注册证书，分别为猪二联灭活疫苗和鸡四联灭活疫苗，监测期均为3年，上市前尚需取得批准文号。两项产品将丰富公司产品线，提升市场竞争力；产品上市前尚需取得批准文号，存在审批及市场推广不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300001475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656319974","title":"每周股票复盘：科前生物（688526）获两项新兽药注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2656319974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656319974?lang=zh_cn&edition=full","pubTime":"2026-08-02 03:29","pubTimestamp":1785612549,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，科前生物报收于13.03元，较上周的12.32元上涨5.76%。科前生物当前最新总市值60.74亿元，在动物保健板块市值排名4/9，在两市A股市值排名2571/5202。本周关注点公司公告汇总：科前生物获批猪流行性腹泻等二联灭活疫苗及鸡新城疫等四联灭活疫苗两项新兽药注册证书。产品上市前尚需取得批准文号，存在审批及市场推广不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200001145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655480633","title":"科前生物（688526）披露获批两项新兽药注册证书，7月30日股价上涨0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655480633","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655480633?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:30","pubTimestamp":1785421832,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，科前生物报收于12.69元，较前一交易日上涨0.48%，最新总市值为59.15亿元。该股当日开盘12.63元，最高12.96元，最低12.62元，成交额达2153.18万元，换手率为0.36%。近日，武汉科前生物股份有限公司发布关于获批新兽药注册证书的自愿性信息披露公告。两项产品将丰富公司产品线，提升市场竞争力。产品上市前尚需取得批准文号，存在审批及市场推广不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000039888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651102442","title":"科前生物（688526）披露拟签订合作研发协议暨关联交易公告，7月14日股价上涨1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651102442","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651102442?lang=zh_cn&edition=full","pubTime":"2026-07-14 23:02","pubTimestamp":1784041344,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，科前生物报收于12.86元，较前一交易日上涨1.18%，最新总市值为59.94亿元。近日，武汉科前生物股份有限公司发布关于拟与华中农业大学、辽宁省动物疫病预防控制中心签订合作研发协议暨关联交易的自愿性披露公告。公司拟共同开展“猪A群轮状病毒阻断ELISA抗体检测试剂盒”项目研发，需向华中农业大学支付20万元研究经费，研发成果及知识产权由公司与华中农业大学共同所有。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400050177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649407692","title":"每周股票复盘：科前生物（688526）将举办2025年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2649407692","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649407692?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:14","pubTimestamp":1783196053,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，科前生物报收于13.04元，较上周的11.84元上涨10.14%。科前生物当前最新总市值60.78亿元，在动物保健板块市值排名4/9，在两市A股市值排名2828/5203。本周关注点公司公告汇总：科前生物将于2026年7月9日举办2025年度业绩说明会 公司公告汇总武汉科前生物股份有限公司将于2026年7月9日14:00-17:00通过全景路演网络平台参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，以网络文字互动方式与投资者交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648420660","title":"科前生物获得发明专利授权：“猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2648420660","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648420660?lang=zh_cn&edition=full","pubTime":"2026-07-04 03:45","pubTimestamp":1783107927,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示科前生物新获得一项发明专利授权，专利名为“猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法”，专利申请号为CN202210642333.9，授权日为2026年7月3日。本发明提供的猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗，在预防此三种猪病，表现出较为显著的优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070400003619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648448725","title":"科前生物（688526）披露将参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，7月01日股价上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648448725","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648448725?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:56","pubTimestamp":1782917773,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，科前生物报收于12.72元，较前一交易日上涨5.12%，最新总市值为59.29亿元。该股当日开盘12.1元，最高12.75元，最低12.07元，成交额达2834.5万元，换手率为0.49%。公告显示，公司将于2026年7月9日14:00-17:00通过全景路演网络平台参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，以网络文字互动方式与投资者交流。参会人员包括董事长、总经理陈慕琳女士及董事会秘书邹天天女士。活动结束后可通过该平台查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643223567","title":"太平洋：给予科前生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2643223567","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643223567?lang=zh_cn&edition=full","pubTime":"2026-06-15 08:10","pubTimestamp":1781482238,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司程晓东,李忠华近期对科前生物进行研究并发布了研究报告《2026年一季报点评：创新驱动穿越周期，宠物疫苗布局打开成长新空间》，给予科前生物买入评级。我们预计公司2026-2028年营收分别达到9.69亿、12.11亿、13.32亿，归母净利润分别为3.91亿、4.37亿、4.94亿，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有10家机构给出评级，买入评级9家，增持评级1家；过去90天内机构目标均价为18.0。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500000403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638655496","title":"科前生物新注册《腺病毒密码子优化软件1.0》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2638655496","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638655496?lang=zh_cn&edition=full","pubTime":"2026-05-26 02:04","pubTimestamp":1779732261,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科前生物新注册了3个项目的软件著作权，包括《腺病毒密码子优化软件1.0》、《DeepiMotif 识别工具（后端）1.0》、《AICellType单细胞注释系统V1.0》等。今年以来科前生物新注册软件著作权5个。通过天眼查大数据分析，武汉科前生物股份有限公司共对外投资了4家企业，参与招投标项目538次；财产线索方面有商标信息65条，专利信息201条，著作权信息2条；此外企业还拥有行政许可509个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600001535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637375275","title":"每周股票复盘：科前生物（688526）每股派现0.64元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2637375275","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637375275?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:12","pubTimestamp":1779567132,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，科前生物报收于14.2元，较上周的14.72元下跌3.53%。本周，科前生物5月18日盘中最高价报14.68元。本周关注点公司公告汇总：科前生物2025年年度权益分派实施，每股派发现金红利0.64元（含税）。本次利润分配以公司总股本466,128,056股为基数，共派发现金红利298,321,955.84元（含税）。分派对象为截至股权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636684654","title":"科前生物（688526）披露2025年年度权益分派实施公告，5月20日股价下跌0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636684654","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636684654?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:36","pubTimestamp":1779273377,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，科前生物报收于14.47元，较前一交易日下跌0.28%，最新总市值为67.45亿元。公司于近日披露《武汉科前生物股份有限公司2025年年度权益分派实施公告》：每股派发现金红利0.64元（含税），股权登记日为2026年5月25日，除权（息）日为2026年5月26日，现金红利发放日为2026年5月26日。分派对象为截至股权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000035918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633921821","title":"股市必读：科前生物一季报 - 第一季度单季净利润同比下降26.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633921821","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633921821?lang=zh_cn&edition=full","pubTime":"2026-05-06 04:20","pubTimestamp":1778012418,"startTime":"0","endTime":"0","summary":"来自业绩披露要点：科前生物2026年一季度归母净利润7923.62万元，同比下降26.79%。公司公告汇总武汉科前生物股份有限公司2025年年度暨2026年第一季度业绩暨现金分红说明会公告武汉科前生物股份有限公司将于2026年5月13日13:00-14:00通过上证路演中心网络互动方式召开2025年年度暨2026年第一季度业绩暨现金分红说明会。投资者可于2026年5月6日至5月12日16:00前通过上证路演中心网站或公司邮箱提交问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633899488","title":"东兴证券：给予科前生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2633899488","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633899488?lang=zh_cn&edition=full","pubTime":"2026-05-05 14:00","pubTimestamp":1777960844,"startTime":"0","endTime":"0","summary":"东兴证券股份有限公司程诗月近期对科前生物进行研究并发布了研究报告《主业经营稳健，坚定研发投入》，给予科前生物买入评级。此外，公司计提了信用减值损失和资产减值损失合计1362.74万。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级7家；过去90天内机构目标均价为18.0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050500003923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","601198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632406996","title":"每周股票复盘：科前生物（688526）一季度净利降26.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632406996","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632406996?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:48","pubTimestamp":1777668491,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，科前生物报收于14.41元，较上周的14.77元下跌2.44%。业绩披露要点：2026年一季报归母净利润7923.62万元，同比下降26.79%。公司公告汇总：科前生物将于2026年5月13日召开年度及一季度业绩说明会。股本股东变化截至2026年3月31日，科前生物股东户数为1.07万户，较2025年12月31日增加5.0户，增幅0.05%。科前生物2025年年度股东会出席会议股东及代理人共118人，代表有表决权股份319,044,688股，占公司总股本的68.4457%，所有议案均获通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660261","title":"科前生物（688526）2026年一季报简析：净利润同比下降26.79%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660261","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632660261?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:50","pubTimestamp":1777589452,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期科前生物发布2026年一季报。截至本报告期末，公司营业总收入2.28亿元，同比下降7.2%，归母净利润7923.62万元，同比下降26.79%。本报告期科前生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达76.33%。然而去年的净利率为43.9%，算上全部成本后，公司产品或服务的附加值极高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100007363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631684675","title":"科前生物(688526)3月31日股东户数1.07万户，较上期增加0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631684675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631684675?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:35","pubTimestamp":1777541713,"startTime":"0","endTime":"0","summary":"户均持股数量由上期的4.38万股减少至4.37万股，户均持股市值为63.5万元。在动物保健行业个股中，科前生物股东户数低于行业平均水平，截至3月31日，动物保健行业平均股东户数为2.23万户。从股价来看，2025年12月31日至2026年3月31日，科前生物区间跌幅为4.85%，在此期间股东户数增加5.0户，增幅为0.05%。根据统计，科前生物2025年12月31日至2026年3月31日，主力资金净流出7142.16万元，游资资金净流入7535.49万元，散户资金净流出393.33万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000056566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631354045","title":"图解科前生物一季报：第一季度单季净利润同比下降26.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631354045","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631354045?lang=zh_cn&edition=full","pubTime":"2026-04-30 02:39","pubTimestamp":1777487958,"startTime":"0","endTime":"0","summary":"证券之星消息，科前生物2026年一季报显示，一季度公司主营收入2.28亿元，同比下降7.2%；归母净利润7923.62万元，同比下降26.79%；扣非净利润6945.19万元，同比下降24.19%；负债率10.62%，投资收益214.55万元，财务费用-1071.75万元，毛利率64.0%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000007728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628786759","title":"每周股票复盘：科前生物（688526）2025年净利增9.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628786759","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2628786759?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:05","pubTimestamp":1776539112,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，科前生物报收于15.1元，较上周的15.05元上涨0.33%。本周，科前生物4月16日盘中最高价报15.25元。公司2025年实现营业收入94,974.20万元，同比增长0.83%；归属于母公司所有者的净利润41,872.32万元，同比增长9.51%。拟每10股派发现金红利6.4元（含税），现金分红及回购合计占净利润71.50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786585977338,"stockEarnings":[{"period":"1week","weight":0.0209},{"period":"1month","weight":0.0354},{"period":"3month","weight":-0.0528},{"period":"6month","weight":-0.1509},{"period":"1year","weight":-0.1997},{"period":"ytd","weight":-0.0969}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉科前生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"10659人(较上一季度增加0.05%)","perCapita":"43730股","listingDate":"2020-09-22","address":"湖北省武汉市江夏区东湖新技术开发区高新二路419号","registeredCapital":"46612万元","survey":" 武汉科前生物股份有限公司的主营业务是专注于兽用生物制品研发、生产、销售及动物防疫技术服务。公司的主要产品是兽用生物制品。公司共获得2项国家科学技术进步奖二等奖、6项湖北省科技进步奖一等奖、1项湖北省科技进步二等奖，5项国家重点新产品证书。","listedPrice":11.69},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科前生物(688526)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科前生物(688526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科前生物,688526,科前生物股票,科前生物股票老虎,科前生物股票老虎国际,科前生物行情,科前生物股票行情,科前生物股价,科前生物股市,科前生物股票价格,科前生物股票交易,科前生物股票购买,科前生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科前生物(688526)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科前生物(688526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}